Evidence map›Paper›PMID 41200459›Full record

ArticleClinical case reports2025

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned!

Mahesh Mathur, Sumit Paudel, Nabita Bhattarai, Sambidha Karki, Sandhya Regmi

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahesh MathurDepartment of Dermatology College of Medical Sciences Teaching Hospital Bharatpur Nepal.
Sumit PaudelDepartment of Dermatology College of Medical Sciences Teaching Hospital Bharatpur Nepal.
Nabita BhattaraiDepartment of Dermatology College of Medical Sciences Teaching Hospital Bharatpur Nepal.ORCID https://orcid.org/0009-0009-2859-0376
Sambidha KarkiDepartment of Dermatology College of Medical Sciences Teaching Hospital Bharatpur Nepal.ORCID https://orcid.org/0009-0003-6438-1930
Sandhya RegmiDepartment of Dermatology College of Medical Sciences Teaching Hospital Bharatpur Nepal.ORCID https://orcid.org/0009-0005-5844-8910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fixed drug eruption (FDE) is a unique type of adverse drug eruption characterized by a well-defined erythematous to violaceous patch that recurs at the same site upon re-exposure to causative drugs and resolves with hyperpigmentation. This distinct drug reaction is a type IV hypersensitivity reaction that is mediated by memory CD8+ T cells that reside in the basal layer of the epidermis of resting FDE lesions. Generalized bullous FDE (GBFDE) is the most severe form of FDE, presenting with widespread blisters and erosions that can be misdiagnosed as epidermal necrolysis. There are only two reports of levocetirizine-induced GBFDE in the literature to date. We hereby present a case of a 65-year-old male with GBFDE due to levocetirizine, which was misattributed to a more commonly implicated drug, that is, acetaminophen.

Indexed as

antihistaminefixed drug eruptiongeneralized bullous fixed drug eruptionlevocetirizinepatch test

Identifiers

PMID41200459
PMCPMC12586341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.